danjames_131

In theory, HATEOS is designed to resolve this problem.

Quick 3 min draft example: https://gist.github.com/djames-bloom/2131d021a8f6d3d09c5a808...

The numbers here seem a bit iffy. While 12 patients underwent the full treatment course with a successful outcome, from the total enrolled in the trial less than 25% reached this state.

It would be interesting to see the reason for the drop-off in the other 39 patients, and for the trial to be replicated on a much wider scale; not to mention, if the method of treatment would be effective with other forms of cancer.

Also worth noting that this was used in conjunction with the standard treatment of chemoradiotherapy and surgery, so with such a small cohort, it's difficult to assess if the PD-1 antibody truly was the key factor in the treatment, or if the standard procedure would have had a successful outcome in each patient alone.

The precedence of it is baffling. Seeing how much money was lost on GME/AMC last year, along with the swathe of suicide-related posts on socials around the LUNA/TERRA debacle, and whatever the hell the NFT market is, you'd think people would realise by this point that there's not only any such thing as a get rich quick scheme, but that in fact, the majority of these swells are simple pump and dump schemes. Combine that with the "impending" recession, we really are facing the roaring 20s version 2, but off of our own hubris.